CA2330567A1 - Lysine containing peptides for treatment of heart disease - Google Patents

Lysine containing peptides for treatment of heart disease Download PDF

Info

Publication number
CA2330567A1
CA2330567A1 CA002330567A CA2330567A CA2330567A1 CA 2330567 A1 CA2330567 A1 CA 2330567A1 CA 002330567 A CA002330567 A CA 002330567A CA 2330567 A CA2330567 A CA 2330567A CA 2330567 A1 CA2330567 A1 CA 2330567A1
Authority
CA
Canada
Prior art keywords
mrp
lys
trp
phe
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002330567A
Other languages
English (en)
French (fr)
Inventor
Romano Deghenghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2330567A1 publication Critical patent/CA2330567A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002330567A 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease Abandoned CA2330567A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/089,955 1998-06-03
US09/089,955 US5932548A (en) 1998-06-03 1998-06-03 Lysine containing peptides for treatment of heart disease
PCT/EP1999/003731 WO1999062539A1 (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Publications (1)

Publication Number Publication Date
CA2330567A1 true CA2330567A1 (en) 1999-12-09

Family

ID=22220375

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002330567A Abandoned CA2330567A1 (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Country Status (11)

Country Link
US (1) US5932548A (cg-RX-API-DMAC7.html)
EP (2) EP1082128B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002516872A (cg-RX-API-DMAC7.html)
AT (1) ATE314083T1 (cg-RX-API-DMAC7.html)
AU (1) AU4371799A (cg-RX-API-DMAC7.html)
CA (1) CA2330567A1 (cg-RX-API-DMAC7.html)
DE (1) DE69929188T2 (cg-RX-API-DMAC7.html)
DK (1) DK1082128T3 (cg-RX-API-DMAC7.html)
ES (1) ES2259834T3 (cg-RX-API-DMAC7.html)
PT (1) PT1082128E (cg-RX-API-DMAC7.html)
WO (1) WO1999062539A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
ATE348163T1 (de) 1998-10-23 2007-01-15 Amgen Inc Thrombopoietin substitute
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
AU2001274601A1 (en) * 2000-06-23 2002-01-02 Kaken Pharmaceutical Co., Ltd. Preventives or remedies for heart failure
EP1417055A4 (en) * 2001-07-19 2007-09-26 Dmi Biosciences Inc USE OF COPPER CHELATORS TO PREVENT THE INACTIVATION OF PROTEIN C
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
AU2004238285A1 (en) * 2003-05-07 2004-11-25 Dmi Biosciences, Inc Oral care methods and products
CA2580796C (en) 2004-09-24 2013-03-26 Amgen Inc. Modified fc molecules having peptides inserted in internal loop regions
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
EP2021015A2 (en) * 2006-04-28 2009-02-11 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
GB2453116B (en) * 2007-09-25 2010-03-17 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methy1-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668254A (en) * 1990-05-11 1997-09-16 Romano Deghenghi D-2-alkyl-tryptophan and peptides containing same
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
EP0783521B8 (en) * 1994-09-27 2003-04-09 Ardana Bioscience Limited Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
SE9703929D0 (sv) * 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutical use and method
US5798102A (en) * 1997-03-04 1998-08-25 Milkhaus Laboratory, Inc. Treatment of cardiomyopathy
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
PT1082128E (pt) 2006-05-31
EP1082128A1 (en) 2001-03-14
US5932548A (en) 1999-08-03
DE69929188D1 (de) 2006-02-02
DK1082128T3 (da) 2006-04-10
WO1999062539A1 (en) 1999-12-09
AU4371799A (en) 1999-12-20
ATE314083T1 (de) 2006-01-15
EP1082128B1 (en) 2005-12-28
ES2259834T3 (es) 2006-10-16
EP1616571A3 (en) 2008-08-13
JP2002516872A (ja) 2002-06-11
EP1616571A2 (en) 2006-01-18
DE69929188T2 (de) 2006-08-17
HK1035863A1 (en) 2001-12-14

Similar Documents

Publication Publication Date Title
US5932548A (en) Lysine containing peptides for treatment of heart disease
US6025471A (en) Diazaspiro, azepino and azabicyclo therapeutic peptides
US4226857A (en) Synthetic peptides having pituitary growth hormone releasing activity
RU2212247C2 (ru) Аналоги пептида лг-рф, их применение и содержащие их фармацевтические композиции
EP0914340B1 (en) hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY
IE882185L (en) Lhrh antagonists
EP0018072B1 (en) Synthetic peptides having pituitary growth hormone releasing activity
WO1997042223A9 (en) hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY
US4504414A (en) Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
PT91384A (pt) Processo para a preparacao de compostos farmaceuticos que compreendem um analogo peptidico da somatostatina
KR100704138B1 (ko) 성장 호르몬 방출 화합물 또는 이들의 길항제를 포함하는 약제학적 조성물
KR100369104B1 (ko) 성장호르몬의유리를촉진하는2-알킬트립토판함유-올리고펩티드화합물
KR20010101079A (ko) Igf-ⅰ 및 -ⅱ를 억제하는 gh-rh의 길항 유사체
US5795957A (en) Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
KR0123009B1 (ko) 쥐이엔알에이취(GnRH) 유사체
Elseviers et al. Evidence for the bioactive conformation in a cyclic hexapeptide analogue of somatostatin containing a cis-peptide bond mimic
SI9111779A (en) Lhrh-antagonists.
Hocart et al. Effect of the CH2NH and CH2NAc peptide bond isosteres on the antagonistic and histamine releasing activities of a luteinizing hormone-releasing hormone analog
Spatola et al. Synthesis and biological activities of pseudopeptide analogues of LH-RH: agonists and antagonists
US5962409A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
Janecka et al. Reduced-size antagonists of luteinizing hormone-releasing hormone active in vitro
HK1083068A (en) Lysine containing peptides for treatment of heart disease
AU768516B2 (en) Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
HK1035863B (en) Lysine containing peptides for treatment of heart disease
HK1008225B (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued